Vaccine update: FDA extends J&J COVID-19 vaccine’s shelf life by extra month-and-a-half; Moderna seeks EUA adjustment to include adolescents and teens

Johnson & Johnson today said the Food and Drug Administration agreed to extend the expiration date for its COVID-19 vaccine by six weeks. The move means the J&J vaccine can now be stored for four-and-a-half months, compared with the original authorization of three months, and helps avert the potential, imminent expiration of millions of unused doses.
Meanwhile, Moderna formally requested that the FDA expand the emergency use authorization for its COVID-19 vaccine to include individuals between the ages of 12 and 17. Moderna had previously reported phase 2/3 trial results indicating 100% efficacy across this age group against COVID-19 when using the same case definition as in adults.
Related News Articles
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…